DNPH1
Basic information
Region (hg38): 6:43225629-43229481
Previous symbols: [ "C6orf108" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNPH1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 0 | 0 |
Variants in DNPH1
This is a list of pathogenic ClinVar variants found in the DNPH1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-43225786-A-G | not specified | Uncertain significance (Jan 23, 2023) | ||
6-43225791-C-G | not specified | Uncertain significance (Apr 04, 2023) | ||
6-43225842-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
6-43225843-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
6-43225858-C-T | not specified | Uncertain significance (Jan 10, 2023) | ||
6-43226044-T-G | not specified | Uncertain significance (Oct 04, 2022) | ||
6-43226045-G-T | not specified | Uncertain significance (Oct 25, 2024) | ||
6-43226063-G-T | not specified | Uncertain significance (Nov 17, 2023) | ||
6-43226084-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
6-43226332-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
6-43229269-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
6-43229377-C-G | not specified | Uncertain significance (Sep 17, 2021) | ||
6-43229411-C-G | not specified | Uncertain significance (Jun 10, 2024) | ||
6-43229427-G-T | not specified | Uncertain significance (Jun 05, 2023) | ||
6-43229438-G-C | not specified | Uncertain significance (Apr 15, 2024) | ||
6-43229441-C-T | not specified | Uncertain significance (Sep 14, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNPH1 | protein_coding | protein_coding | ENST00000230431 | 4 | 3856 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0321 | 0.828 | 125677 | 0 | 23 | 125700 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.638 | 78 | 95.5 | 0.816 | 0.00000597 | 1056 |
Missense in Polyphen | 23 | 35.917 | 0.64036 | 399 | ||
Synonymous | -0.110 | 40 | 39.1 | 1.02 | 0.00000217 | 376 |
Loss of Function | 1.16 | 3 | 6.09 | 0.493 | 2.61e-7 | 71 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000491 | 0.000489 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000975 | 0.0000967 |
Middle Eastern | 0.000491 | 0.000489 |
South Asian | 0.0000983 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the cleavage of the N-glycosidic bond of deoxyribonucleoside 5'-monophosphates to yield deoxyribose 5- phosphate and a purine or pyrimidine base. Deoxyribonucleoside 5'- monophosphates containing purine bases are preferred to those containing pyrimidine bases. {ECO:0000255|HAMAP-Rule:MF_03036, ECO:0000269|PubMed:24260472, ECO:0000269|PubMed:25108359}.;
- Pathway
- Nucleobase catabolism;Metabolism of nucleotides;Metabolism;Purine catabolism
(Consensus)
Recessive Scores
- pRec
- 0.152
Haploinsufficiency Scores
- pHI
- 0.0728
- hipred
- N
- hipred_score
- 0.177
- ghis
- 0.609
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnph1
- Phenotype
Gene ontology
- Biological process
- purine nucleotide catabolic process;cell population proliferation;nucleoside metabolic process;deoxyribonucleoside monophosphate catabolic process;positive regulation of cell growth;epithelial cell differentiation
- Cellular component
- nucleus;cytosol;extracellular exosome
- Molecular function
- protein binding;identical protein binding;protein homodimerization activity;deoxyribonucleoside 5'-monophosphate N-glycosidase activity